SHE:300705 - Hunan Jiudian Pharmaceutical Co Ltd

Hunan Jiudian Pharmaceutical C
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2013 Q4	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q1	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.32B 20.1%	1.45B 10.2%	1.63B 12.2%	1.8B 10.5%	1.93B 7.1%	2.1B 8.8%	2.33B 10.9%	2.38B 2.3%	2.51B 5.6%	2.62B 4.3%	2.69B 2.8%	2.78B 3.3%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	295.2M 14.2%	314.47M 6.5%	349.9M 11.3%	380.97M 8.9%	420.84M 10.5%	460.55M 9.4%	516.98M 12.3%	549.06M 6.2%	561.73M 2.3%	586.4M 4.4%	615.22M 4.9%	650.94M 5.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.02B 22.0%	1.14B 11.3%	1.28B 12.4%	1.42B 10.9%	1.51B 6.2%	1.64B 8.7%	1.81B 10.5%	1.83B 1.1%	1.95B 6.6%	2.03B 4.2%	2.08B 2.1%	2.13B 2.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.12B 18.4%	1.21B 8.5%	1.37B 13.2%	1.53B 11.6%	1.65B 7.6%	1.79B 9.0%	2B 11.8%	2.04B 1.7%	2.14B 4.8%	2.19B 2.4%	2.28B 4.2%	2.31B 1.2%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	820.1M 20.0%	895.66M 9.2%	1.02B 13.9%	1.15B 12.6%	1.22B 6.6%	1.33B 8.8%	1.49B 11.6%	1.49B 0.2%	1.57B 5.7%	1.6B 1.7%	1.66B 4.0%	1.66B -0.5%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	201.3M 30.6%	240.81M 19.6%	257.26M 6.8%	269.07M 4.6%	281.34M 4.6%	304.28M 8.2%	321.76M 5.7%	339.85M 5.6%	376.59M 10.8%	432.33M 14.8%	412.61M -4.6%	473.95M 14.9%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	162.25M -	-	204.25M -	-	221.2M -	-	269.7M -	-	337.56M -	-	368.26M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	162.25M 33.4%	196.29M 21.0%	204.25M 4.1%	213.76M 4.7%	221.2M 3.5%	243.42M 10.0%	269.7M 10.8%	290.62M 7.8%	337.56M 16.2%	371.3M 10.0%	368.26M -0.8%	417.04M 13.2%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.493 32.7%	0.593 20.3%	0.621 4.8%	0.65 4.6%	0.671 3.3%	0.731 8.9%	0.82 12.1%	0.87 6.1%	1.01 16.1%	1.09 7.9%	1.07 -1.8%	1.21 13.1%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.493 32.7%	0.593 20.3%	0.621 4.8%	0.65 4.6%	0.671 3.3%	0.731 8.9%	0.82 12.1%	0.87 6.1%	1.01 16.1%	1.09 7.9%	1.07 -1.8%	1.21 13.1%